Osteosarcoma, American Journal of Clinical Pathology, vol.125, issue.4, pp.327-345, 1989. ,
DOI : 10.1309/UC6KQHLD9LV2KENN
Enzinger and Weiss' Soft Tissue Tumors, 2001. ,
Effect of Timing of Pulmonary Metastases Identification on Prognosis of Patients With Osteosarcoma: The Japanese Musculoskeletal Oncology Group Study, Journal of Clinical Oncology, vol.20, issue.16, pp.3470-3477, 2002. ,
DOI : 10.1200/JCO.2002.11.028
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling, Cytokine & Growth Factor Reviews, vol.15, issue.6, pp.457-475, 2004. ,
DOI : 10.1016/j.cytogfr.2004.06.004
Receptor Activator of Nuclear Factor ??B Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis, The American Journal of Pathology, vol.163, issue.5, pp.2021-2031, 2003. ,
DOI : 10.1016/S0002-9440(10)63560-2
Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases, Journal of Clinical Pathology, vol.55, issue.11, pp.877-878, 2002. ,
DOI : 10.1136/jcp.55.11.877
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation, Endocrinology, vol.140, issue.10, pp.4451-4458, 1999. ,
DOI : 10.1210/en.140.10.4451
Molecular mechanisms of tumorbone interactions in osteolytic metastases, Crit Rev Eukaryot Gene Expr, vol.10, pp.159-178, 2000. ,
Alteration of Integrins by Heparin-Binding EGF Like Growth Factor in Human Breast Cancer Cells, Oncology, vol.53, issue.5, pp.374-381, 1996. ,
DOI : 10.1159/000227591
Inhibition of lung metastasis of osteosarcoma cell line POS-1 transplanted into mice by thigh ligation, Cancer Letters, vol.188, issue.1-2, pp.213-219, 2002. ,
DOI : 10.1016/S0304-3835(02)00433-0
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities, Experimental Cell Research, vol.293, issue.2, pp.292-301, 2004. ,
DOI : 10.1016/j.yexcr.2003.10.016
Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKC?? and STAT3, Journal of Bone and Mineral Research, vol.100, issue.Suppl, pp.1850-1861, 2004. ,
DOI : 10.1359/JBMR.040817
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts, Biochemical and Biophysical Research Communications, vol.305, issue.2, pp.211-214, 2003. ,
DOI : 10.1016/S0006-291X(03)00695-8
Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway, Journal of Biological Chemistry, vol.276, issue.31, pp.29028-29036, 2001. ,
DOI : 10.1074/jbc.M011265200
Establishment and characterisation of an osteoblastic clonal cell line from human mandibular osteosarcoma (HMOS-1), Oral Oncology, vol.33, issue.3, pp.163-168, 1997. ,
DOI : 10.1016/S0964-1955(96)00075-9
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation, Cell, vol.89, issue.5, pp.747-754, 1997. ,
DOI : 10.1016/S0092-8674(00)80257-3
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities, Microscopy Research and Technique, vol.97, issue.6, pp.504-513, 2003. ,
DOI : 10.1002/jemt.10374
Establishment and characterization of tartrate-resistant acid phosphatase and alkaline phosphatase double positive cell lines, Cell and Tissue Research, vol.304, issue.3, pp.351-359, 2001. ,
DOI : 10.1007/s004410100347
Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning, Anticancer Res, vol.23, pp.2201-2216, 2003. ,
Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells, International Immunopharmacology, vol.2, issue.1, pp.25-38, 2002. ,
DOI : 10.1016/S1567-5769(01)00134-5
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts, Journal of Cellular Biochemistry, vol.95, issue.4, pp.650-659, 1998. ,
DOI : 10.1002/jcb.10436
The osteoclastassociated protease cathepsin K is expressed in human breast carcinoma, Cancer Res, vol.57, pp.5386-5390, 1997. ,
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression, Journal of Bone and Mineral Research, vol.43, issue.2, pp.222-230, 2003. ,
DOI : 10.1359/jbmr.2003.18.2.222
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma, Blood, vol.98, issue.13, pp.3534-3540, 2001. ,
DOI : 10.1182/blood.V98.13.3534
Osteoprotegerin inhibits prostate cancer???induced osteoclastogenesis and prevents prostate tumor growth in the bone, Journal of Clinical Investigation, vol.107, issue.10, pp.1235-1244, 2001. ,
DOI : 10.1172/JCI11685
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma, Cancer Res, vol.61, pp.1637-1644, 2001. ,
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand, Proceedings of the National Academy of Sciences, vol.96, issue.7, pp.3540-3545, 1999. ,
DOI : 10.1073/pnas.96.7.3540
RANK ligand directly induces osteoclastogenic, angiogenic, chemoattractive and invasive factors on RANK-expressing human cancer cells MDA-MB-231 and PC3, J Bone Miner Res, vol.19, p.25, 2004. ,
Bone Morphogenetic Protein (BMP)-2 Induces Apoptosis in Human Myeloma Cells, Leukemia & Lymphoma, vol.94, issue.3, pp.635-639, 2002. ,
DOI : 10.1016/S1074-7613(00)80011-4
Antiproliferatiye effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units, Anti-Cancer Drugs, vol.9, issue.4, pp.327-331, 1998. ,
DOI : 10.1097/00001813-199804000-00006
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1704, issue.2, pp.49-57, 2004. ,
DOI : 10.1016/j.bbcan.2004.05.002
URL : https://hal.archives-ouvertes.fr/inserm-00669006